These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31861249)

  • 1. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.
    Salcher S; Spoden G; Huber JM; Golderer G; Lindner H; Ausserlechner MJ; Kiechl-Kohlendorfer U; Geiger K; Obexer P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.
    Tan Y; Zhou Y; Zhang W; Wu Z; Xu Q; Wu Q; Yang J; Lv T; Yan L; Luo H; Shi Y; Yang J
    Cell Oncol (Dordr); 2024 Aug; 47(4):1167-1181. PubMed ID: 38326640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
    Salcher S; Spoden G; Hagenbuchner J; Führer S; Kaserer T; Tollinger M; Huber-Cantonati P; Gruber T; Schuster D; Gust R; Zwierzina H; Müller T; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Oncogene; 2020 Jan; 39(5):1080-1097. PubMed ID: 31591479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.
    Rupp M; Hagenbuchner J; Rass B; Fiegl H; Kiechl-Kohlendorfer U; Obexer P; Ausserlechner MJ
    Oncogene; 2017 Nov; 36(44):6190-6203. PubMed ID: 28869600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.
    Salcher S; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Mol Cancer; 2017 May; 16(1):95. PubMed ID: 28545464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma.
    Hagenbuchner J; Rupp M; Salvador C; Meister B; Kiechl-Kohlendorfer U; Müller T; Geiger K; Sergi C; Obexer P; Ausserlechner MJ
    Oncotarget; 2016 Nov; 7(47):77591-77606. PubMed ID: 27769056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma.
    Salcher S; Hagenbuchner J; Geiger K; Seiter MA; Rainer J; Kofler R; Hermann M; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
    Mol Cancer; 2014 Sep; 13():224. PubMed ID: 25261981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
    Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
    Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma.
    Geiger K; Hagenbuchner J; Rupp M; Fiegl H; Sergi C; Meister B; Kiechl-Kohlendorfer U; Müller T; Ausserlechner MJ; Obexer P
    Mol Biol Cell; 2012 Jun; 23(11):2226-34. PubMed ID: 22493319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
    Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
    Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating FOXO3 transcriptional activity by small, DBD-binding molecules.
    Hagenbuchner J; Obsilova V; Kaserer T; Kaiser N; Rass B; Psenakova K; Docekal V; Alblova M; Kohoutova K; Schuster D; Aneichyk T; Vesely J; Obexer P; Obsil T; Ausserlechner MJ
    Elife; 2019 Dec; 8():. PubMed ID: 31789593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.
    Obexer P; Hagenbuchner J; Unterkircher T; Sachsenmaier N; Seifarth C; Böck G; Porto V; Geiger K; Ausserlechner M
    Mol Biol Cell; 2009 Apr; 20(7):2041-8. PubMed ID: 19211844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis.
    Zhang L; Cai M; Gong Z; Zhang B; Li Y; Guan L; Hou X; Li Q; Liu G; Xue Z; Yang MH; Ye J; Chin YE; You H
    J Clin Invest; 2017 Jun; 127(6):2159-2175. PubMed ID: 28436938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine.
    Duan ZQ; Li Y; Li L
    Immunol Res; 2017 Oct; 65(5):1074-1082. PubMed ID: 28905195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA 195-5p Targets
    Bai Y; Pan B; Zhan X; Silver H; Li J
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14.
    Ding X; Xiang L; Wang N; Zhao Z; Jin X; Sun Y; Duan W; Wang S; Jin X
    Oncol Rep; 2014 Mar; 31(3):1165-74. PubMed ID: 24399074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma.
    Zang Y; Dong Q; Lu Y; Dong K; Wang R; Liang Z
    Aging (Albany NY); 2021 Jan; 13(3):4388-4408. PubMed ID: 33493133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
    Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
    Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.